Last Price
9.90
Today's Change
+0.33 (3.44%)
Day's Change
9.70 - 12.00
Trading Volume
4,031,910
Profile
BMEA
Exchange: NASDAQ Global Select NASDAQ Global Select
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Thomas Andrew Butler Mr. Thomas Andrew Butler
Full Time Employees: 112 112
IPO Date: 2021-04-16 2021-04-16
CIK: 0001840439 0001840439
ISIN: US09077A1060 US09077A1060
CUSIP: 09077A106 09077A106
Beta: -0.49 -0.49
Last Dividend: 0.00 0.00
Dcf Diff: 5.10 5.10
Dcf: 4.88 4.88
Description
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in Redwood City, California.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
Intel Gets Multibillion-dollar Apollo Offer as Qualcomm Circles
2
CEO Morning Brief
3
CEO Morning Brief
Citigroup's China Expansion Held Up by US Regulators — Bloomberg
4
CEO Morning Brief
US Worries Deepen as Adversaries Team Up to Challenge Dominance
5
CEO Morning Brief
Brazil Sugar Losses Make Thai and Indian Supply More Important
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
